The Prevalence of Irregular Erythrocyte Antibodies Among Antenatal Women in Delhi

Overview

Journal Blood Transfus

Specialty Hematology

Date 2011 Aug 16

PMID 21839025

Citations 41

Authors

Sangeeta Pahuja

Santosh Kumar Gupta

Mukta Pujani

Manjula Jain

Affiliations

Soon will be listed here.

Abstract

Background: Universal screening of all antenatal women, including D antigen-positive pregnant ones, is mandatory in most developed countries. However, no guidelines on this issue are available for developing countries such as India. Furthermore, there is limited information on immunisation rates in pregnant women (D antigen-positive and D antigen-negative) from India. We, therefore, studied the prevalence of alloantibodies among multigravida women in India.

Materials And Methods: In this prospective study, carried out to detect the prevalence of alloantibodies among multigravida women in India, 3,577 multigravida women attending antenatal clinics were typed for ABO and D antigens and screened for alloantibodies by column agglutination technology. The medical history and detailed obstetric history of these women were reviewed and information recorded on any prior haemolytic disease of the foetus and newborn among siblings and/or blood transfusions.

Results: The overall prevalence of alloantibodies in this study was 1.25%. There was a statistically significant difference between alloimmunisation rates in the D antigen-negative and D antigen-positive groups (10.7% versus 0.12%, respectively). Anti-D antibody contributed to 78.4% of total alloimmunisations in our study.

Discussion: Anti-D was the most common culprit responsible for alloimmunisation. Other alloantibodies found included anti-C, anti-M, anti-S and anti-c. Large-scale population-based studies are required to assess the real magnitude of alloimmunisation in pregnant women in India.

Citing Articles

Comparing red cell alloantibody detection and titration by gel microcolumn agglutination method with conventional tube in Rh-negative antenatal cases.

Dubey R, Biswas A, Asthana B, Pawar A, Dimri U, Baranwal A Med J Armed Forces India. 2025; 80(6):651-656.

PMID: 39990532 PMC: 11842921. DOI: 10.1016/j.mjafi.2023.01.012.

Dual Maternal Alloimmunization by Antibodies of Rhesus and MNSs Blood Group System: Case Series and Approach to Work Up in a Resource Limited Set Up.

Pahuja S, Chauhan S, Sharma G, Singh D Indian J Hematol Blood Transfus. 2025; 41(1):161-166.

PMID: 39917485 PMC: 11794840. DOI: 10.1007/s12288-024-01801-2.

[Cell salvage in obstetrics-Background and practical implementation].

Kotlyar M, Neef V, Rumpf F, Meybohm P, Zacharowski K, Kranke P Anaesthesiologie. 2024; 73(12):843-851.

PMID: 39542885 PMC: 11615018. DOI: 10.1007/s00101-024-01479-1.

Hemolytic Disease of the Fetus and Newborn Caused by Maternal Alloanti-Fy(a).

Robins R, I S, Haran A H, James S Cureus. 2024; 16(9):e69395.

PMID: 39403655 PMC: 11472332. DOI: 10.7759/cureus.69395.

Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion.

Golia S, Tiwari A, Aggarwal G, Khetrapal A, Tyagi S, Jain C Asian J Transfus Sci. 2024; 18(1):45-50.

PMID: 39036694 PMC: 11259351. DOI: 10.4103/ajts.ajts_46_23.

References

Lurie S, Eliezer E, Piper I, Woliovitch I . Is antibody screening in Rh (D)-positive pregnant women necessary?. J Matern Fetal Neonatal Med. 2004; 14(6):404-6. DOI: 10.1080/14767050412331312260. View

Adeniji A, Fuller I, Dale T, Lindow S . Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?. J Matern Fetal Neonatal Med. 2007; 20(1):59-61. DOI: 10.1080/14767050601123317. View

. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med. 1996; 6(1):71-4. View

de Vrijer B, Oosterbaan H . [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch]. Ned Tijdschr Geneeskd. 2000; 143(50):2523-7. View

Chandrasekar A, Morris K, Tubman T, Tharma S, McClelland W . The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland. Ulster Med J. 2002; 70(2):89-94. PMC: 2449233. View

Solola A, Sibai B, Mason J . Irregular antibodies: an assessment of routine prenatal screening. Obstet Gynecol. 1983; 61(1):25-30. View

Filbey D, Hanson U, Wesstrom G . The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand. 1995; 74(9):687-92. DOI: 10.3109/00016349509021175. View

Gottvall T, Filbey D . Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol Scand. 2008; 87(8):843-8. DOI: 10.1080/00016340802268880. View

Semmekrot B, de Man A, Boekkooi P, van Dijk B . [Irregular blood group antibodies during pregnancy: screening is mandatory]. Ned Tijdschr Geneeskd. 1999; 143(28):1449-52. View

10.

Koelewijn J, Vrijkotte T, van der Schoot C, Bonsel G, de Haas M . Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008; 48(5):941-52. DOI: 10.1111/j.1537-2995.2007.01625.x. View

11.

Lee C, Ma E, Tang M, Lam C, Lin C, Chan L . Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001. Transfus Med. 2003; 13(4):227-31. DOI: 10.1046/j.1365-3148.2003.00445.x. View

12.

Lenkiewicz B, Zupanska B . [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)]. Ginekol Pol. 2003; 74(1):48-54. View

13.

Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I . Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed. 1998; 78(1):F62-6. PMC: 1720748. DOI: 10.1136/fn.78.1.f62. View

14.

Wu K, Chu S, Chang J, Shih M, Peng C . Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfus Med. 2003; 13(5):311-4. DOI: 10.1046/j.1365-3148.2003.00458.x. View